Streetbeat News

Earnings

PODD

Insulet (NASDAQ:PODD) has received mixed analyst ratings over the last three months, with a shift towards more bullish perspectives in the last 30 days. The average 12-month price target for Insulet has been raised to $227.0, indicating a 17.25% increase from the previous target. Analysts from firms like Piper Sandler, JP Morgan, Stifel, Baird, and Morgan Stanley have adjusted their ratings and price targets, reflecting their evolving views on Insulet's market performance. Insulet's financial indicators such as revenue growth, net margin, ROE, ROA, and debt management are highlighted, showcasing the company's strong financial health and performance.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:00 pm

MODV

ModivCare Inc (NASDAQ:MODV) reported Q4 2023 revenue of $702.8 million, a 7.5% increase year-over-year, surpassing consensus estimates. Despite revenue growth, driven by an increase in non-emergency medical transportation trips and personal care services hours, the company's adjusted EPS fell to $1.29 from $2.11 a year ago, slightly above consensus. The decrease in membership due to Medicaid redetermination and margin pressure in the NEMT segment were noted as challenges. Deutsche Bank and Jefferies downgraded MODV, significantly lowering their price targets. ModivCare forecasts lower than expected revenues for Q1 2024 and the full year, contributing to a 40.6% drop in its stock price.

Portfolio Pulse from Vandana Singh

February 23, 2024 | 6:54 pm

AAPL

AMZN

GOOG

META

MSFT

NVDA

QQQ

SPY

TSLA

The stock market reached a new high, driven by a renewed AI frenzy, particularly after NVIDIA Corp's earnings announcement, which saw its stock value surge by a record $277B in one day. This AI enthusiasm has overshadowed concerns such as high interest rates and overestimated earnings outside of AI. Early trade money flows show positive trends for Meta Platforms, Microsoft, and NVIDIA, neutral for Apple and Alphabet, and negative for Amazon and Tesla. Mixed money flows are observed in SPDR S&P 500 ETF Trust and Invesco QQQ Trust. The article also notes the impact on gold, oil, and Bitcoin markets, with specific ETFs mentioned for each.

Portfolio Pulse from The Arora Report

February 23, 2024 | 6:36 pm

Guardant Health Inc (NASDAQ:GH) reported Q4 2023 sales of $155.1 million, up 22% Y/Y, beating consensus. Precision oncology revenue grew 25% to $142.2 million. The company expects 2024 revenue of $655-$670 million. The FDA AdCom meeting for Shield CRC is delayed to Q2 but approval is still expected in 2024. Canaccord Genuity lowered GH's price target to $45 from $50. GH shares fell 11.8% to $19.64.

Portfolio Pulse from Vandana Singh

February 23, 2024 | 6:35 pm

ALLE

JCI

Mizuho Securities analyst Brett Linzey downgraded Allegion Plc (ALLE) and Johnson Controls International Plc (JCI) to Neutral from Buy, citing market challenges and mixed performance. ALLE's Q4 earnings beat expectations but sales missed, while JCI's Q1 revenues fell short with an adjusted EPS outlook revision. Linzey raised ALLE's price target slightly but maintained JCI's, expressing concerns over non-residential market signals and execution abilities.

Portfolio Pulse from Lekha Gupta

February 23, 2024 | 6:28 pm

CVNA

Carvana Co (NYSE:CVNA) shares surged following its Q4 earnings report, with analysts from RBC Capital Markets, Wedbush, JMP Securities, Needham, and William Blair providing positive outlooks despite mixed results. The company's strong EBITDA guidance and record retail non-GAAP gross profit per unit were highlights, leading to increased price targets and reaffirmed ratings.

Portfolio Pulse from Priya Nigam

February 23, 2024 | 6:23 pm

LYV

Live Nation Entertainment's CEO, Michael Rapino, appeared on CNBC to discuss the company's earnings, highlighting that they achieved record revenue.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 6:20 pm

EVER

EverQuote (NASDAQ:EVER) is scheduled to release its quarterly earnings report on Monday, 2024-02-26, with an expected EPS of $-0.32. Analysts and investors are keen on not just the earnings beat or miss but also the company's guidance for future growth. Historical data shows mixed reactions to past earnings reports, with the last quarter missing EPS estimates but resulting in a 16.94% share price increase the following day. Over the last year, EverQuote's shares have decreased by 5.48%, indicating potential concern among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 6:02 pm

KNOP

KNOT Offshore Partners (NYSE:KNOP) is scheduled to release its quarterly earnings report on 2024-02-26, with analysts expecting an EPS of $0.05. The company's past performance shows a tendency to beat EPS estimates, which has previously led to positive stock price movements. Shares are currently trading at $5.5, down 12.44% over the last year. Investors will be keenly watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 6:02 pm

CAPL

CrossAmerica Partners (NYSE:CAPL) is scheduled to release its quarterly earnings report on 2024-02-26, with analysts estimating an EPS of $0.22. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in a slight share price drop. Shares have increased by 2.65% over the last 52 weeks, indicating a generally positive trend. Investors will be keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 6:02 pm